rewirebio.iobenchmarks
Configuration

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)

MGISEQ-200 short-read mNGS workflow, a configuration of Harmonised mNGS analysis workflow: NGS (MGI platform).

3 evaluations · 54 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

3 evaluations · 54 results. Different protocols are not a single leaderboard.

Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)

Sorted by False negatives (sequencing negative, comparator positive; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT)) (lower is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetFalse negatives (sequencing negative, comparator positive; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))False negatives (sequencing negative, comparator positive; organism level; organisms: all organisms; reference: composite reference standard (CRS))False negatives (sequencing negative, comparator positive; organism level; organisms: all organisms; reference: routine culture)False negatives (sequencing negative, comparator positive; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))False negatives (sequencing negative, comparator positive; organism level; organisms: bacteria; reference: composite reference standard (CRS))False negatives (sequencing negative, comparator positive; organism level; organisms: bacteria; reference: routine culture)False negatives (sequencing negative, comparator positive; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))False negatives (sequencing negative, comparator positive; organism level; organisms: fungi; reference: composite reference standard (CRS))False negatives (sequencing negative, comparator positive; organism level; organisms: fungi; reference: routine culture)False positives (sequencing positive, comparator negative; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))False positives (sequencing positive, comparator negative; organism level; organisms: all organisms; reference: composite reference standard (CRS))False positives (sequencing positive, comparator negative; organism level; organisms: all organisms; reference: routine culture)False positives (sequencing positive, comparator negative; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))False positives (sequencing positive, comparator negative; organism level; organisms: bacteria; reference: composite reference standard (CRS))False positives (sequencing positive, comparator negative; organism level; organisms: bacteria; reference: routine culture)False positives (sequencing positive, comparator negative; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))False positives (sequencing positive, comparator negative; organism level; organisms: fungi; reference: composite reference standard (CRS))False positives (sequencing positive, comparator negative; organism level; organisms: fungi; reference: routine culture)Recall (positive percent agreement; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))Recall (positive percent agreement; organism level; organisms: all organisms; reference: composite reference standard (CRS))Recall (positive percent agreement; organism level; organisms: all organisms; reference: routine culture)Recall (positive percent agreement; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))Recall (positive percent agreement; organism level; organisms: bacteria; reference: composite reference standard (CRS))Recall (positive percent agreement; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))Recall (positive percent agreement; organism level; organisms: fungi; reference: composite reference standard (CRS))Recall (sensitivity; organism level; organisms: bacteria; reference: routine culture)Recall (sensitivity; organism level; organisms: fungi; reference: routine culture)Specificity (negative percent agreement; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))Specificity (negative percent agreement; organism level; organisms: all organisms; reference: composite reference standard (CRS))Specificity (negative percent agreement; organism level; organisms: all organisms; reference: routine culture)Specificity (negative percent agreement; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))Specificity (negative percent agreement; organism level; organisms: bacteria; reference: composite reference standard (CRS))Specificity (negative percent agreement; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))Specificity (negative percent agreement; organism level; organisms: fungi; reference: composite reference standard (CRS))Specificity (specificity; organism level; organisms: bacteria; reference: routine culture)Specificity (specificity; organism level; organisms: fungi; reference: routine culture)True negatives (concordant negative; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))True negatives (concordant negative; organism level; organisms: all organisms; reference: composite reference standard (CRS))True negatives (concordant negative; organism level; organisms: all organisms; reference: routine culture)True negatives (concordant negative; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))True negatives (concordant negative; organism level; organisms: bacteria; reference: composite reference standard (CRS))True negatives (concordant negative; organism level; organisms: bacteria; reference: routine culture)True negatives (concordant negative; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))True negatives (concordant negative; organism level; organisms: fungi; reference: composite reference standard (CRS))True negatives (concordant negative; organism level; organisms: fungi; reference: routine culture)True positives (concordant positive; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))True positives (concordant positive; organism level; organisms: all organisms; reference: composite reference standard (CRS))True positives (concordant positive; organism level; organisms: all organisms; reference: routine culture)True positives (concordant positive; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))True positives (concordant positive; organism level; organisms: bacteria; reference: composite reference standard (CRS))True positives (concordant positive; organism level; organisms: bacteria; reference: routine culture)True positives (concordant positive; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))True positives (concordant positive; organism level; organisms: fungi; reference: composite reference standard (CRS))True positives (concordant positive; organism level; organisms: fungi; reference: routine culture)
MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)EvaluationOrganism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)5Not reportedNot reported3Not reportedNot reported2Not reportedNot reported13Not reportedNot reported10Not reportedNot reported4Not reportedNot reported88.6%Not reportedNot reported89.7%Not reported84.6%Not reportedNot reportedNot reported75%Not reportedNot reported80%Not reported92.9%Not reportedNot reportedNot reported39Not reportedNot reported40Not reportedNot reported52Not reportedNot reported39Not reportedNot reported26Not reportedNot reported11Not reportedNot reported
MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)EvaluationOrganism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)Not reported5Not reportedNot reported3Not reportedNot reported2Not reportedNot reported13Not reportedNot reported10Not reportedNot reported4Not reportedNot reported93.3%Not reportedNot reported94%Not reported89.5%Not reportedNot reportedNot reported77.6%Not reportedNot reported83.3%Not reported93.2%Not reportedNot reportedNot reported45Not reportedNot reported50Not reportedNot reported55Not reportedNot reported70Not reportedNot reported47Not reportedNot reported17Not reported
MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)EvaluationOrganism-level agreement with routine culture, 62 BALF specimens (Hu et al. 2026)Not reportedNot reported1Not reportedNot reported1Not reportedNot reported0Not reportedNot reported31Not reportedNot reported26Not reportedNot reported8Not reportedNot reported95.2%Not reportedNot reportedNot reportedNot reported93.3%100%Not reportedNot reported44.6%Not reportedNot reportedNot reportedNot reported54.4%85.7%Not reportedNot reported25Not reportedNot reported31Not reportedNot reported48Not reportedNot reported20Not reportedNot reported14Not reportedNot reported4
All 54 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
5 False negatives (sequencing negative, comparator positive; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Clinical microbiological tests (CMT)", row "−" (sequencing negative), column "+" (comparator positive)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
13 False positives (sequencing positive, comparator negative; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Clinical microbiological tests (CMT)", row "+" (sequencing positive), column "−" (comparator negative)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
75% Specificity (negative percent agreement; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Clinical microbiological tests (CMT)", row "NPA"
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
88.6% Recall (positive percent agreement; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Clinical microbiological tests (CMT)", row "PPA"
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
39 True negatives (concordant negative; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Clinical microbiological tests (CMT)", row "−" (sequencing negative), column "−" (comparator negative)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
39 True positives (concordant positive; organism level; organisms: all organisms; reference: clinical microbiological tests (CMT))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Clinical microbiological tests (CMT)", row "+" (sequencing positive), column "+" (comparator positive)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
3 False negatives (sequencing negative, comparator positive; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 6, block "NGS", column group "Clinical microbiological tests (CMT)", row "−" (sequencing negative), column "+" (comparator positive)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
10 False positives (sequencing positive, comparator negative; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 6, block "NGS", column group "Clinical microbiological tests (CMT)", row "+" (sequencing positive), column "−" (comparator negative)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
80% Specificity (negative percent agreement; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 6, block "NGS", column group "Clinical microbiological tests (CMT)", row "NPA"
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
89.7% Recall (positive percent agreement; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 6, block "NGS", column group "Clinical microbiological tests (CMT)", row "PPA"
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
40 True negatives (concordant negative; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 6, block "NGS", column group "Clinical microbiological tests (CMT)", row "−" (sequencing negative), column "−" (comparator negative)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
26 True positives (concordant positive; organism level; organisms: bacteria; reference: clinical microbiological tests (CMT))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 6, block "NGS", column group "Clinical microbiological tests (CMT)", row "+" (sequencing positive), column "+" (comparator positive)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
2 False negatives (sequencing negative, comparator positive; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 7, block "NGS", column group "Clinical microbiological tests (CMT)", row "−" (sequencing negative), column "+" (comparator positive)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
4 False positives (sequencing positive, comparator negative; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 7, block "NGS", column group "Clinical microbiological tests (CMT)", row "+" (sequencing positive), column "−" (comparator negative)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
92.9% Specificity (negative percent agreement; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 7, block "NGS", column group "Clinical microbiological tests (CMT)", row "NPA"
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
84.6% Recall (positive percent agreement; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 7, block "NGS", column group "Clinical microbiological tests (CMT)", row "PPA"
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
52 True negatives (concordant negative; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 7, block "NGS", column group "Clinical microbiological tests (CMT)", row "−" (sequencing negative), column "−" (comparator negative)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
11 True positives (concordant positive; organism level; organisms: fungi; reference: clinical microbiological tests (CMT))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against clinical microbiological tests (CMT)

dna-pathogen-20261011-hu2026-protocol-cmt

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 7, block "NGS", column group "Clinical microbiological tests (CMT)", row "+" (sequencing positive), column "+" (comparator positive)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
5 False negatives (sequencing negative, comparator positive; organism level; organisms: all organisms; reference: composite reference standard (CRS))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against composite reference standard (CRS)

dna-pathogen-20261011-hu2026-protocol-crs

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Composite reference standard (CRS)", row "−" (sequencing negative), column "+" (comparator positive)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
13 False positives (sequencing positive, comparator negative; organism level; organisms: all organisms; reference: composite reference standard (CRS))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against composite reference standard (CRS)

dna-pathogen-20261011-hu2026-protocol-crs

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Composite reference standard (CRS)", row "+" (sequencing positive), column "−" (comparator negative)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
77.6% Specificity (negative percent agreement; organism level; organisms: all organisms; reference: composite reference standard (CRS))
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against composite reference standard (CRS)

dna-pathogen-20261011-hu2026-protocol-crs

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Composite reference standard (CRS)", row "NPA"
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
93.3% Recall (positive percent agreement; organism level; organisms: all organisms; reference: composite reference standard (CRS))
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against composite reference standard (CRS)

dna-pathogen-20261011-hu2026-protocol-crs

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Composite reference standard (CRS)", row "PPA"
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
45 True negatives (concordant negative; organism level; organisms: all organisms; reference: composite reference standard (CRS))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against composite reference standard (CRS)

dna-pathogen-20261011-hu2026-protocol-crs

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Composite reference standard (CRS)", row "−" (sequencing negative), column "−" (comparator negative)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
70 True positives (concordant positive; organism level; organisms: all organisms; reference: composite reference standard (CRS))
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against composite reference standard (CRS)

dna-pathogen-20261011-hu2026-protocol-crs

Aggregation: Not reported

Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Table 2, block "NGS", column group "Composite reference standard (CRS)", row "+" (sequencing positive), column "+" (comparator positive)
Configuration: MGISEQ-200 short-read mNGS workflow (Hu et al. 2026)Protocol: Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)
Dataset: 62 residual BALF specimens with culture results (Hu et al. 2026)
3 False negatives (sequencing negative, comparator positive; organism level; organisms: bacteria; reference: composite reference standard (CRS))
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MGISEQ-200 short-read mNGS workflow (Hu et al. 2026) against composite reference standard (CRS)

dna-pathogen-20261011-hu2026-protocol-crs

Aggregation: Not reported

Hu et al. 2026 Supplemental Tables S1 to S4, S6 and S7 (spectrum.03993-25-s0001.docx) · Supplemental Table 6, block "NGS", column group "Composite reference standard (CRS)", row "−" (sequencing negative), column "+" (comparator positive)

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Use this configuration

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: dna-pathogen-20261011-hu2026-config-mgi

areas
microbes-communities
contexts
clinical_research
method types
conventional_pipeline
reported name
NGS (MGI platform)
source locator
Methods 'NGS workflows', 'Bioinformatic processing and taxonomic assignment' and 'Read normalization, reporting threshold, and contamination control'; Results 'Diagnostic performance for clinical samples' paragraph 1
foundation model eligible
false
parameters
Bead beating and TIANGEN Microsample Genomic DNA extraction; VAHTS Universal Plus DNA library for MGI; MGISEQ-200 single-end 50 bp; DUST and quality filtering; Bowtie2 host removal against GRCh38 plus plasmids; BWA-MEM to the curated database; LCA; positive if RP20M >= 3; contaminants flagged above the 95th percentile of historical negative controls
access reuse
Laboratory workflow described in the article; not released as software
missing metadata
version: reason: unreported; note: Guppy, Bowtie2, BWA-MEM and minimap2 versions and the database build date are not stated
provenance note
NGS (MGI platform) as run on the clinical BALF specimens in Hu et al. 2026.
Related records

Suggest a correction